RPTOR and muscular dystrophy: Although previous studies have demonstrated the ability of rapamycin to reduce the dystrophic phenotype in some models of muscular dystrophy, complete ablation of mTORC1 signaling through knockout of raptor, an obligate member of mTORC1, leads to a dystrophic phenotype in mice [30, 33, 53].